Biden Signs Order to Boost Biomanufacturing, Compete with China
- High-tech production has migrated overseas in recent years
- US policies developed to compete with growing Chinese industry
The Covid-19 pandemic created a sense of urgency around developing a clear and consistent industrial strategy, according to two of the people, who pointed to the fast development and production of messenger RNA vaccines as an example of successful domestic investment.
Photographer: Nick Oxford/BloombergThis article is for subscribers only.
President Joe Biden signed an executive order laying out a strategy to bolster domestic biomanufacturing and reduce reliance on China for new medicines, chemicals and other products.
Biden signed the order Monday morning before giving a speech in Boston. The White House will also hold a summit Sept. 14 to discuss the initiative and announce new investments in domestic research, development and production capabilities, according to a statement.